United States· US:63102-140_f35e67f4-4a6e-4340-9b6d-60cdbf33b412
ACTINEL Diabetic
A medicinal product containing dextromethorphan hydrobromide; guaifenesin, registered in United States by ACTIPHARMA, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
- Manufacturer
- ACTIPHARMA, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1163102-140-16
- ndc116310214016473 mL in 1 BOTTLE, PLASTIC (63102-140-16)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dextromethorphan hydrobromide; guaifenesin in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaBENYLIN REGULAR STRENGTH COUGH PLUS CHEST CONGESTION RELIEFMCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
- SpainBRONCOMEDICAL CON GUAIFENESINA 10 mg/100 mg SOLUCION ORALMedical S.A.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Spain · Broncomedical Con Guaifenesina, Cinfatós Expectorante
- Italy · Bronchenolo Sedativo E Fluidificante, Bronchenolo Sedativo E Fluidificante Gusto Menta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/30a7f264-666a-4837-9258-c0e933b5b2ce GET /v1/drugs/30a7f264-666a-4837-9258-c0e933b5b2ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "10; 100",
"substance": "DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN",
"productndc": "63102-140",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "mg/5mL; mg/5mL",
"application_number": "M012",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about dextromethorphan hydrobromide; guaifenesin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.